Skip to main content
NCBI home page
British Journal of Pharmacology and Chemotherapy logoLink to British Journal of Pharmacology and Chemotherapy
. 1961 Dec;17(3):310–320. doi: 10.1111/j.1476-5381.1961.tb01118.x

Relative activity of some inhibitors of monoamine oxidase in potentiating the action of tryptamine in vitro and in vivo

D R Maxwell, W R Gray, E M Taylor
PMCID: PMC1482079  PMID: 14471627

Abstract

Several known inhibitors of mono-amine oxidase (iproniazid, isocarboxazid, nialamide, phenelzine, pheniprazine and tranylcypromine) were tested for their ability to (i) inhibit the mono-amine oxidase activity of a rat brain mitochondrial preparation in vitro; (ii) potentiate the action of tryptamine on the isolated rat fundal strip preparation; and (iii) potentiate the acute toxicity of tryptamine in mice. There was some correlation between the order of potency of the drugs in the three tests, particularly in inhibiting the enzyme activity in the Warburg and in the tryptamine toxicity test in mice. Exceptions to this were isocarboxazid which had unexpectedly high activity on the rat fundal strip preparation, and tranylcypromine which was devoid of tryptamine-potentiation action on the rat fundus preparation although it inhibited rat brain mono-amine oxidase in vitro and potentiated the action of tryptamine in vivo. Tranylcypromine was considerably less active in inhibiting the mono-amine oxidase of rat fundus than rat brain tissue in vitro, while iproniazid and isocarboxazid had about the same potency on the enzyme from the two tissues.

Full text

PDF
310

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BARLOW R. B. Effects on amine oxidase of substances which antagonize 5-hydroxytryptamine more than tryptamine on the rat fundus strip. Br J Pharmacol Chemother. 1961 Apr;16:153–162. doi: 10.1111/j.1476-5381.1961.tb00308.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. BRODIE B. B., HOGBEN C. A. Some physico-chemical factors in drug action. J Pharm Pharmacol. 1957 Jun;9(6):345–380. doi: 10.1111/j.2042-7158.1957.tb12289.x. [DOI] [PubMed] [Google Scholar]
  3. DAVISON A. N. The mechanism of the irreversible inhibition of rat-liver monoamine oxidase by iproniazid (marsilid). Biochem J. 1957 Oct;67(2):316–322. doi: 10.1042/bj0670316. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. HOGBEN C. A., TOCCO D. J., BRODIE B. B., SCHANKER L. S. On the mechanism of intestinal absorption of drugs. J Pharmacol Exp Ther. 1959 Apr;125(4):275–282. [PubMed] [Google Scholar]
  5. PLETSCHER A., GEY K. F. Stereospecificity of monoamine oxidase inhibitors. Science. 1958 Oct 17;128(3329):900–901. doi: 10.1126/science.128.3329.900. [DOI] [PubMed] [Google Scholar]
  6. SHORE P. A., BRODIE B. B., HOGBEN C. A. The gastric secretion of drugs: a pH partition hypothesis. J Pharmacol Exp Ther. 1957 Mar;119(3):361–369. [PubMed] [Google Scholar]
  7. SJOERDSMA A., OATES J. A., ZALTZMAN P., UDENFRIEND S. Identification and assay of urinary tryptamine: application as an index of monoamine oxidase inhibition in man. J Pharmacol Exp Ther. 1959 Jul;126(3):217–222. [PubMed] [Google Scholar]
  8. TEDESCHI D. H., TEDESCHI R. E., FELLOWS E. J. The effects of tryptamine on the central nervous system, including a pharmacological procedure for the evaluation of iproniazidlike drugs. J Pharmacol Exp Ther. 1959 Jul;126(3):223–232. [PubMed] [Google Scholar]
  9. VANE J. R. A sensitive method for the assay of 5-hydroxytryptamine. Br J Pharmacol Chemother. 1957 Sep;12(3):344–349. doi: 10.1111/j.1476-5381.1957.tb00146.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. VANE J. R. The relative activities of some tryptamine analogues on the isolated rat stomach strip preparation. Br J Pharmacol Chemother. 1959 Mar;14(1):87–98. doi: 10.1111/j.1476-5381.1959.tb00933.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology and Chemotherapy are provided here courtesy of The British Pharmacological Society

RESOURCES